These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8933105)

  • 1. Some analytical considerations on the measurement of prostate-specific antigen.
    Blijenberg BG; Kranse R; Eman I; Schröder FH
    Eur J Clin Chem Clin Biochem; 1996 Oct; 34(10):817-21. PubMed ID: 8933105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assay variability in serum prostate-specific antigen determination.
    Brawer MK; Daum P; Petteway JC; Wener MH
    Prostate; 1995 Jul; 27(1):1-6. PubMed ID: 7541527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abbott IMx evaluated for assay of prostate-specific antigen in serum.
    Dnistrian AM; Schwartz MK; Smith CA; Nisselbaum JS; Fair WR
    Clin Chem; 1992 Oct; 38(10):2140-2. PubMed ID: 1382898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparability of serum prostate-specific antigen measurement between the hybritech Tandem-R and Abbott AxSYM assays.
    Leewansangtong S; Goktas S; Lepoff R; Holthaus K; Crawford ED
    Urology; 1998 Sep; 52(3):467-9. PubMed ID: 9730462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical evaluation of the new Prostatus PSA Free/Total assay for prostate-specific antigen as part of a screening study for prostate cancer.
    Blijenberg BG; Bangma CH; Kranse R; Eman I; Schröder FH
    Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):111-4. PubMed ID: 9056753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in measurement of prostate-specific antigen: importance of method and lot variability.
    Wener MH; Daum PR; Brawer MK
    Clin Chem; 1995 Dec; 41(12 Pt 1):1730-7. PubMed ID: 7497613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic significance of prostate-specific antigen velocity at intermediate PSA serum levels in relation to the standard deviation of different test systems.
    Manseck A; Pilarsky C; Froschermaier S; Menschikowski M; Wirth MP
    Urol Int; 1998; 60(1):25-7. PubMed ID: 9519417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology.
    Roehrborn CG; Gregory A; McConnell JD; Sagalowsky AI; Wians FH
    Urology; 1996 Dec; 48(6A Suppl):23-32. PubMed ID: 8973696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of serum prostate specific antigen using IMx prostate specific antigen assay.
    Klee GG; Dodge LA; Zincke H; Oesterling JE
    J Urol; 1994 Jan; 151(1):94-8. PubMed ID: 7504749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in the standardization of total prostate-specific antigen.
    Blijenberg BG; Storm BN; Van Zelst BD; Kruger AE; Schröder FH
    Clin Biochem; 1999 Nov; 32(8):627-34. PubMed ID: 10638945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of 'ultrasensitive' prostate-specific antigen assays in the detection of biochemical recurrence after radical prostatectomy.
    van Iersel MP; Thomas CM; Segers MF; Witjes WP; Debruyne FM; Oosterhof GO
    Br J Urol; 1996 Mar; 77(3):418-22. PubMed ID: 8814849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays.
    Zhou AM; Tewari PC; Bluestein BI; Caldwell GW; Larsen FL
    Clin Chem; 1993 Dec; 39(12):2483-91. PubMed ID: 7504592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen.
    Vessella RL; Noteboom J; Lange PH
    Clin Chem; 1992 Oct; 38(10):2044-54. PubMed ID: 1382897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The variation of percent free prostate-specific antigen determined by two different assays.
    Yang CR; Ou YC; Horng YY; Lee HS
    Anticancer Res; 2003; 23(1B):707-11. PubMed ID: 12680171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of assays for prostate-specific antigen molecular forms.
    Kuriyama M; Uno H; Ueno K; Hamamoto Y; Vihn PQ; Ban Y
    Jpn J Clin Oncol; 1999 Jun; 29(6):303-7. PubMed ID: 10418560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analytical comparison of the three most commonly used prostate-specific antigen assays: Tandem-R, Tandem-E, and IMx.
    Oesterling JE; Moyad MA; Wright GL; Beck GR
    Urology; 1995 Oct; 46(4):524-32. PubMed ID: 7571222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical issues on prostate-specific antigen in relation to prostate cancer screening.
    Blijenberg BG; Roobol M; Schröder FH
    Clin Biochem; 1998 Nov; 31(8):633-9. PubMed ID: 9876895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparability of the Tandem-R and IMx assays for the measurement of serum prostate-specific antigen.
    Jacobsen SJ; Lilja H; Klee GG; Wright GL; Pettersson K; Oesterling JE
    Urology; 1994 Oct; 44(4):512-8. PubMed ID: 7524236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical performance of the Tandem-R free PSA immunoassay measuring free prostate-specific antigen.
    Woodrum DL; French CM; Hill TM; Roman SJ; Slatore HL; Shaffer JL; York LG; Eure KL; Loveland KG; Gasior GH; Southwick PC; Shamel LB
    Clin Chem; 1997 Jul; 43(7):1203-8. PubMed ID: 9216457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparability of serum prostate-specific antigen measurement between the Roche Diagnostics Elecsys 2010 and the Abbott Architect i2000.
    Gray MA; Cooke RR; Weinstein P; Nacey JN
    Ann Clin Biochem; 2004 May; 41(Pt 3):207-12. PubMed ID: 15117434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.